Point72 Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58.4M Sell
238,800
-658,800
-73% -$153M 0.07% 313
2025
Q4
$186M Buy
897,600
+895,800
+49,767% +$177M 0.21% 63
2025
Q3
$334K Hold
1,800
﹤0.01% 2040
2025
Q2
$275K Sell
1,800
-4,700
-72% -$722K ﹤0.01% 1927
2025
Q1
$1.08M Sell
6,500
-5,200
-44% -$814K ﹤0.01% 1423
2024
Q4
$1.69M Sell
11,700
-6,600
-36% -$1.02M ﹤0.01% 1295
2024
Q3
$2.97M Sell
18,300
-1,100
-6% -$175K 0.01% 1047
2024
Q2
$2.84M Sell
19,400
-13,400
-41% -$1.99M 0.01% 998
2024
Q1
$5.19M Sell
32,800
-81,000
-71% -$12.9M 0.01% 954
2023
Q4
$17.8M Sell
113,800
-31,200
-22% -$4.78M 0.04% 473
2023
Q3
$22.6M Buy
145,000
+100,900
+229% +$16.6M 0.07% 369
2023
Q2
$7.3M Sell
44,100
-25,100
-36% -$4.05M 0.02% 680
2023
Q1
$10.7M Buy
69,200
+11,100
+19% +$1.79M 0.03% 531
2022
Q4
$10.3M Buy
58,100
+33,100
+132% +$5.72M 0.03% 543
2022
Q3
$4.08M Hold
25,000
0.02% 778
2022
Q2
$4.44M Buy
+25,000
New +$4.45M 0.02% 739
2019
Q2
Sell
-100,000
Closed -$14M 1436
2019
Q1
$14M Buy
+100,000
New +$13.4M 0.06% 331

Other funds holding JNJ

Point72 Asset Management's JNJ Position: Q1 2026 in Review

Point72 Asset Management sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 120,604 shares — an estimated $28.1M sold.

Point72 Asset Management first reported a position in JNJ in Q4 2016 and held it in 18 quarters. The position peaked at $159M in Q4 2018. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Point72 Asset Management reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 120,604 Johnson & Johnson shares in Q1 2026, an estimated $28.1M.
  • Point72 Asset Management first reported a position in Johnson & Johnson in Q4 2016 and held it in 18 quarters.
  • Point72 Asset Management's Johnson & Johnson position peaked at $159M in Q4 2018.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.